Open Orphan (LON:ORPH) presentation by Cathal Friel, Co-Founder

ORPH came out of a reverse takeover of Venn Life Sciences earlier this year. Cathal Friel outlines what they’re up to, and their vision.

Introduction – 00:18
A pharma services company – 02:02
The founders – 03:14
The orphan drug sector – 06:48
Combining high-margin pharma with digital & data offerings – 10:35
Founders investment – 12:15
Transforming Venn Life Sciences – 13:04
Targetting to add Eu30m in high margin revenues by 2022 – 15:45
Virtual Rep & Access platform – 18:45
Open Orphan’s Geonomic Health Data Platform – 23:03
Summary – 28:15
Q&A – 30:45

Unlock the rest of this Article in 15 seconds

or Unlock with your email

Already have an account?
Login here